Tweet
<img alt="" height="1" width="1" />
Amylin shares fall after new Bydureon data hits
Reuters
NEW YORK, June 15 (Reuters) - Amylin Pharmaceuticals Inc (AMLN.O) and Eli Lilly and Co's (LLY.N) experimental diabetes drug Bydureon proved better at reducing blood sugar levels than one currently marketed medicine, ...
Amylin Drug Fails To Beat GenericForbes (blog)
Amylin Pharmaceuticals shares fall on comparison study for diabetes drug BydureonCanadianBusiness.com
Study confirms Bydureon potential, says LillyBusiness Financial News Wire
MarketWatch (press release) -RTT News
all 46 news articles »
More...